603 related articles for article (PubMed ID: 15056004)
1. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S
J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Rossi F; Turini P; Ortuso F; Alcaro S; Cardia MC
Eur J Med Chem; 2008 Oct; 43(10):2262-7. PubMed ID: 18281126
[TBL] [Abstract][Full Text] [Related]
4. Enantiomers of C(5)-chiral 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives: Analytical and semipreparative HPLC separation, chiroptical properties, absolute configuration, and inhibitory activity against monoamine oxidase.
Cirilli R; Ferretti R; Gallinella B; Turchetto L; Bolasco A; Secci D; Chimenti P; Pierini M; Fares V; Befani O; La Torre F
Chirality; 2004 Nov; 16(9):625-36. PubMed ID: 15382204
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
Palaska E; Aydin F; Uçar G; Erol D
Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
Chimenti F; Carradori S; Secci D; Bolasco A; Bizzarri B; Chimenti P; Granese A; Yáñez M; Orallo F
Eur J Med Chem; 2010 Feb; 45(2):800-4. PubMed ID: 19926363
[TBL] [Abstract][Full Text] [Related]
8. Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B.
Silvestri R; La Regina G; De Martino G; Artico M; Befani O; Palumbo M; Agostinelli E; Turini P
J Med Chem; 2003 Mar; 46(6):917-20. PubMed ID: 12620068
[TBL] [Abstract][Full Text] [Related]
9. A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.
Gökhan-Kelekçi N; Yabanoğlu S; Küpeli E; Salgin U; Ozgen O; Uçar G; Yeşilada E; Kendi E; Yeşilada A; Bilgin AA
Bioorg Med Chem; 2007 Sep; 15(17):5775-86. PubMed ID: 17611112
[TBL] [Abstract][Full Text] [Related]
10. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Cirilli R; La Torre F; Alcaro S; Ortuso F; Langer T
Curr Med Chem; 2006; 13(12):1411-28. PubMed ID: 16719786
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.
Vishnu Nayak B; Ciftci-Yabanoglu S; Jadav SS; Jagrat M; Sinha BN; Ucar G; Jayaprakash V
Eur J Med Chem; 2013 Nov; 69():762-7. PubMed ID: 24099995
[TBL] [Abstract][Full Text] [Related]
14. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of human monoamine oxidase inhibitory activities of some 3,5-diaryl-N-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives.
Sentürk K; Tan OU; Ciftçi SY; Uçar G; Palaska E
Arch Pharm (Weinheim); 2012 Sep; 345(9):695-702. PubMed ID: 22674756
[TBL] [Abstract][Full Text] [Related]
17. Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors.
Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Befani O; Turini P; Ortuso F; Alcaro S
J Med Chem; 2007 Feb; 50(3):425-8. PubMed ID: 17266193
[TBL] [Abstract][Full Text] [Related]
18. Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors.
Shi L; Yang Y; Li ZL; Zhu ZW; Liu CH; Zhu HL
Bioorg Med Chem; 2010 Feb; 18(4):1659-64. PubMed ID: 20117937
[TBL] [Abstract][Full Text] [Related]
19. Development of selective and reversible pyrazoline based MAO-B inhibitors: virtual screening, synthesis and biological evaluation.
Mishra N; Sasmal D
Bioorg Med Chem Lett; 2011 Apr; 21(7):1969-73. PubMed ID: 21377879
[TBL] [Abstract][Full Text] [Related]
20. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
